(NASDAQ:MBOT), BRAINTREE, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY(R) Endovascular Robotic System, today announced the appointment of Ms. Michal Ahuvia, to the newly created role of Director of Operations. In this role, Ms. Ahuvia will assume responsibility to ramp-up production and improve production efficiencies as […]

TORONTO, Jan. 21, 2025 (GLOBE NEWSWIRE) — CourseCompare, Canada's marketplace for education, which serves more than two million prospective students from more than 100 countries each year, has released its 2025 rankings of the best schools and programs in Canada. This year's rankings examine over 45 categories including business schools, online universities, trade schools, and

(NASDAQ:VERB),(NASDAQ:VERBW), First Episode To Air Prime Time Thursday at 7pm ET January 30, 2025New Prime Time Thursday Episodes To Air Each Week Across Cheddar TV's Cable and Streaming Networks And Online Platforms LOS ALAMITOS, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or the “Company”), the technology company behind

(NASDAQ:SCOR), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — Proximic by Comscore, a division of Comscore, Inc. (NASDAQ: SCOR) and a leading provider of audience and content targeting solutions for programmatic activation, today released its third annual State of Programmatic Report for 2025. A key finding shows that 72% of respondents are planning to increase

(NASDAQ:BRY), DALLAS, Jan. 21, 2025 (GLOBE NEWSWIRE) — Berry Corporation (bry) (NASDAQ: BRY) (“Berry” or the “Company”) today announced the appointment of Jeff Magids as the Company's Vice President, Chief Financial Officer, effective January 21, 2025. Mike Helm will continue in his position as Vice President, Chief Accounting Officer. Jeff's extensive experience, including in finance,

REDWOOD CITY, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) — Bluejay Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing therapeutics for serious viral and liver diseases, today announced that its lead product candidate brelovitug (also known as BJT-778) has received U.S. Food and Drug Administration (FDA) Breakthrough Therapy designation for the treatment of chronic

(NYSE MKT:KULR), HOUSTON, Jan. 21, 2025 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a leader in advanced energy management platforms, today announced it has increased its bitcoin purchases for its Bitcoin Treasury by an additional $8 million to reach a total of $50 million in bitcoin acquisitions. The

(NASDAQ:MYGN), SALT LAKE CITY, Jan. 21, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced a study revealing that more patients completed hereditary cancer testing when they used an online screening tool and received education about genetic testing. The study was published in Obstetrics & Gynecology

LOS ANGELES, Jan. 21, 2025 (GLOBE NEWSWIRE) — Economists often predict the future by projecting that what's happening right now will continue. Payden & Rygel takes a different approach in Profiles of the Future: Our 2025 Macro Outlook, imagining how interest rates, inflation, employment and asset performance may surprise us in 2025. “We've suggested spending

(NASDAQ:JNVR), BOCA RATON, FL, Jan. 21, 2025 (GLOBE NEWSWIRE) — Janover Inc. (Nasdaq: JNVR) (“Janover” or the “Company”), an AI-enabled platform connecting the commercial real estate industry, today announced the exciting, continued growth of its AI SaaS and marketplace platform for the multifamily and commercial real estate industry. Blake Janover, CEO of Janover, stated, “The